A recent study in the journal Neural Regeneration Research sheds light on the molecular mechanisms of optic nerve injury, offering new avenues for neuro-restorative strategies. Researchers Xiaxue Chen, Muyang Wei, and Guangyu Li employed cutting-edge transcriptomic technologies, such as single-cell RNA sequencing and CRISPR-Cas9 screening, to investigate the response of retinal ganglion cells (RGCs) to injury in models of optic nerve crush (ONC) and glaucoma.
The study reveals that different RGC subtypes exhibit distinct survival and regeneration capabilities following optic nerve injury. Single-cell RNA sequencing identified genes such as Gal, Ucn, and Anxa2, which are associated with RGC protection and regeneration. In the glaucoma model, transcriptomic changes under elevated intraocular pressure were analyzed, pointing to genes involved in immune response, oxidative stress, and apoptosis. These genes may play a crucial role in neuroprotection and axon regeneration.
Additionally, through CRISPR-Cas9 screening and ATAC-seq analyses, the study identified transcription factors that regulate RGC survival and regeneration. These findings offer novel therapeutic approaches for treating optic nerve damage, particularly in glaucoma, the second leading cause of blindness worldwide.
The authors emphasize that future research should integrate single-cell sequencing with multi-omics approaches to better understand specific cellular responses. Computational modeling and systems biology could aid in predicting molecular pathways and advancing clinical research on optic nerve regeneration.
Source: Chen, X., Wei, M., & Li, G. (2026). Molecular mechanisms after optic nerve injury: Neurorepair strategies from a transcriptomic perspective. Neural Regeneration Research, 21(3), 989-999. DOI: 10.4103/NRR.NRR-D-24-00794
